← All stocks

Immunome Inc.

IMNM Scheduled selling only

CIK 0001472012 #1696 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$334.22K

$0.00 on a plan · $334.22K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$334.22K

$0.00 against sales at will

By person

10 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Higgins Jack

Chief Scientific Officer

—

$334.22K (1) scheduled

−$334.22K

60,250

0.0530%

$1.53M

+314.7%

SIEGALL CLAY B

President and CEO

—

870,704

0.7666%

$22.05M

+107.5%

WAGENHEIM PHILIP

Director

—

341,147

0.3004%

$8.64M

−16.0%

Rosett Max

Chief Financial Officer

—

101,287

0.0892%

$2.56M

+410.1%

Barchas Isaac

Director

—

92,211

0.0812%

$2.33M

−89.7%

Tsai Philip

Chief Technical Officer

—

81,550

0.0718%

$2.06M

—

Lechleider Robert

Chief Medical Officer

—

69,805

0.0615%

$1.77M

—

Stoneman Sandra G.

CHIEF LEGAL OFFICER & GC

—

43,805

0.0386%

$1.11M

+688.6%

BIENAIME JEAN JACQUES

Director

—

43,415

0.0382%

$1.10M

+161.3%

Horn Kinney

CHIEF BUSINESS OFFICER

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 26,800

History held since 5 Oct 2020